CWM
AVDL

CIBC World Markets’s Avadel Pharmaceuticals AVDL Stock Holding History

CIBC World Markets’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$97.4K Sell
11,008
-9,500
-46% -$83.5K ﹤0.01% 1404
2025
Q1 		$161K Buy
+20,508
New +$172K ﹤0.01% 1520

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's AVDL Position: Q2 2025 in Review

CIBC World Markets reduced its Avadel Pharmaceuticals (AVDL) stake by 46% in Q2 2025, selling an estimated $83.5K and leaving 11,008 shares worth $97.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

CIBC World Markets first reported a position in AVDL in Q1 2025 and has held it in 2 quarters since. The position peaked at $161K in Q1 2025. 173 funds tracked by Wall St. Rank hold AVDL as of Q2 2025.

  • CIBC World Markets held 11,008 shares of Avadel Pharmaceuticals worth $97.4K as of Q2 2025.
  • CIBC World Markets sold 9,500 Avadel Pharmaceuticals shares in Q2 2025, an estimated $83.5K.
  • Avadel Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1404 holding.
  • CIBC World Markets first reported a position in Avadel Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Avadel Pharmaceuticals position peaked at $161K in Q1 2025.
  • 173 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.